Home › Funds › NEA Management Company, LLC › GLUE

NEA Management Company, LLC position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

NEA Management Company, LLC reported holding 6,692,298 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$79.8M, representing 5.85% of its reported portfolio and ranking #7 among its reported holdings. NEA Management Company, LLC has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.69M sh
Reported value held$79.84M
Portfolio Weight5.85%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How NEA Management Company, LLC's GLUE position evolved

NEA Management Company, LLC first disclosed a stake in GLUE in Q3 2023 at 7,692,298 shares (US$36.8M). The position peaked in Q2 2026 at 7,692,298 shares, worth US$186.2M. Across 13 filings, NEA Management Company, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 6,692,298 shares valued at US$79.8M — a reduction of -1,000,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.69M $36.85M New
Q4 2023 7.69M $43.46M Hold
Q1 2024 7.69M $54.23M Hold
Q2 2024 7.69M $28.77M Hold
Q3 2024 7.69M $40.77M Hold
Q4 2024 7.69M $53.38M Hold
Q1 2025 7.69M $35.69M Hold
Q2 2025 7.69M $34.69M Hold
Q3 2025 7.69M $57.00M Hold
Q4 2025 7.69M $120.62M Hold
Q1 2026 7.69M $126.54M Hold
Q2 2026 7.69M $186.15M Hold
Q3 2026 6.69M $79.84M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in GLUE — the largest reported positions include Vestal Point Capital, LP (US$85.1M), BAKER BROS. ADVISORS LP (US$51.8M), BVF INC/IL (US$51.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has NEA Management Company, LLC held GLUE?

NEA Management Company, LLC has disclosed GLUE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is NEA Management Company, LLC's current position in GLUE?

As of Q3 2026, NEA Management Company, LLC holds 6.69M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $79.84M, representing 5.85% of its reported portfolio and ranking #7.

Has NEA Management Company, LLC been buying or selling GLUE?

In the latest 13F filing (Q3 2026), NEA Management Company, LLC reduced its position in GLUE. The position peaked in Q2 2026 at 7.69M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include Vestal Point Capital, LP, BAKER BROS. ADVISORS LP, BVF INC/IL, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.